Form 483 Roundup: FDA Cracks Down on Non-Sterile Workplaces

Drug GMP Report
A A
The FDA cited two compounders and two drugmakers for failure to maintain aseptic conditions and for other shortcomings, as reflected in Form 483 inspection reports.

To View This Article:

Login

Subscribe To Drug GMP Report